BACKGROUND AND AIMS: IL-is important in gastric damage, mucosal repair and gastric cancer progression. We analysed IL-11 expression in H.pylori infected mouse stomach, the site of gastric IL-11 expression in mice and humans, and the effect of exogenous IL-11 on gastric mucosal homeostasis. METHODS: IL-11 protein was localised in mouse and human stomach. The impact of chronic, exogenous IL-11 on normal mouse stomach was examined histologically and transcriptionally by microarray, confirmed by mRNA and protein analysis. Functional impact of IL-11 on gastric acid secretion was determined. RESULTS: In mice infected with H.pylori, IL-11 was increased in fundic mucosa with temporal expression similar to IL-1b. IL-11 protein was localised predominantly to parietal cells in mouse and human stomach. Application of exogenous IL-11 to resulted in fundic parietal and chief cell loss, hyperplasia, mucous cell metaplasia and inflammation. Coincident with cellular changes were an increased gastric pH, altered parietal cell ultrastructure and altered gene expression, particularly genes involved in immune response and ion transport which could result in compromised acid secretion. We confirmed that a single dose of IL-11 effectively ablated the gastric response to histamine. CONCLUSIONS: IL-11 is a parietal cell cytokine that blocks gastric acid secretion, likely via reducing expression of parietal cell ion transport genes, CCKb and histamine H2 receptors. IL-11 expression is increased in H. pylori infected mouse stomach and treatment of wild type mice with IL-11 induced changes in the gastric fundic mucosa reminiscent of chronic atrophic gastritis, a precursor to gastric cancer.
BACKGROUND AND AIMS: IL-is important in gastric damage, mucosal repair and gastric cancer progression. We analysed IL-11 expression in H.pylori infected mouse stomach, the site of gastric IL-11 expression in mice and humans, and the effect of exogenous IL-11 on gastric mucosal homeostasis. METHODS:IL-11 protein was localised in mouse and human stomach. The impact of chronic, exogenous IL-11 on normal mouse stomach was examined histologically and transcriptionally by microarray, confirmed by mRNA and protein analysis. Functional impact of IL-11 on gastric acid secretion was determined. RESULTS: In mice infected with H.pylori, IL-11 was increased in fundic mucosa with temporal expression similar to IL-1b. IL-11 protein was localised predominantly to parietal cells in mouse and human stomach. Application of exogenous IL-11 to resulted in fundic parietal and chief cell loss, hyperplasia, mucous cell metaplasia and inflammation. Coincident with cellular changes were an increased gastric pH, altered parietal cell ultrastructure and altered gene expression, particularly genes involved in immune response and ion transport which could result in compromised acid secretion. We confirmed that a single dose of IL-11 effectively ablated the gastric response to histamine. CONCLUSIONS:IL-11 is a parietal cell cytokine that blocks gastric acid secretion, likely via reducing expression of parietal cell ion transport genes, CCKb and histamine H2 receptors. IL-11 expression is increased in H. pylori infected mouse stomach and treatment of wild type mice with IL-11 induced changes in the gastric fundic mucosa reminiscent of chronic atrophic gastritis, a precursor to gastric cancer.
Authors: F Nicoletti; P Zaccone; I Conget; R Gomis; C Möller; P L Meroni; K Bendtzen; W Trepicchio; S Sandler Journal: Diabetes Date: 1999-12 Impact factor: 9.461
Authors: Mark J Ropeleski; Jun Tang; Margaret M Walsh-Reitz; Mark W Musch; Eugene B Chang Journal: Gastroenterology Date: 2003-05 Impact factor: 22.682
Authors: Nhung V Nguyen; Paul A Gleeson; Nathalie Courtois-Coutry; Michael J Caplan; Ian R Van Driel Journal: Gastroenterology Date: 2004-07 Impact factor: 22.682
Authors: K Matsuo; M Oka; K Murase; H Soda; H Isomoto; F Takeshima; Y Mizuta; I Murata; S Kohno Journal: J Int Med Res Date: 2003 Mar-Apr Impact factor: 1.671
Authors: Christine P Petersen; Anne R Meyer; Carlo De Salvo; Eunyoung Choi; Cameron Schlegel; Alec Petersen; Amy C Engevik; Nripesh Prasad; Shawn E Levy; R Stokes Peebles; Theresa T Pizarro; James R Goldenring Journal: Gut Date: 2017-02-14 Impact factor: 23.059
Authors: Kvin Lertpiriyapong; Mark T Whary; Sureshkumar Muthupalani; Jennifer L Lofgren; Eric R Gamazon; Yan Feng; Zhongming Ge; Timothy C Wang; James G Fox Journal: Gut Date: 2013-06-28 Impact factor: 23.059
Authors: Jon N Buzzelli; Dan I Pavlic; Heather V Chalinor; Louise O'Connor; Trevelyan R Menheniott; Andrew S Giraud; Louise M Judd Journal: Oncotarget Date: 2015-01-20
Authors: Jesper A B Strickertsson; Claus Desler; Tomas Martin-Bertelsen; Ana Manuel Dantas Machado; Torkel Wadstrøm; Ole Winther; Lene Juel Rasmussen; Lennart Friis-Hansen Journal: PLoS One Date: 2013-04-30 Impact factor: 3.240
Authors: Mohamad El-Zaatari; John Y Kao; Art Tessier; Longchuan Bai; Michael M Hayes; Clinton Fontaine; Kathryn A Eaton; Juanita L Merchant Journal: PLoS One Date: 2013-03-08 Impact factor: 3.240
Authors: Louise M Judd; Treve R Menheniott; Hui Ling; Cameron B Jackson; Meegan Howlett; Anastasia Kalantzis; Waldemar Priebe; Andrew S Giraud Journal: PLoS One Date: 2014-05-07 Impact factor: 3.240